Literature DB >> 724325

The use of furosemide in the treatment of edema in infants and children.

M A Engle, J E Lewy, P R Lewy, J Metcoff.   

Abstract

One hundred thirty-seven courses of furosemide therapy were given to 106 hospitalized pediatric patients with salt and water retention associated with cardiac or renal disease. The diuretic was effective and safe in the pediatric age group when administered acutely as a parenteral medication and over a long-term course by the oral route in the doses and at the time intervals used in this study. On the basis of each kilogram of body weight, the infants with edema as a result of cardiac failure and the children with edema secondary to renal disease responded equally well to furosemide therapy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 724325

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

Review 1.  Approach to a Child with Congestive Heart Failure.

Authors:  Manojkumar Rohit; Sudhansu Budakoty
Journal:  Indian J Pediatr       Date:  2020-04       Impact factor: 1.967

Review 2.  Diuretic therapy in children.

Authors:  C M Whight
Journal:  Indian J Pediatr       Date:  1988 Sep-Oct       Impact factor: 1.967

3.  Pharmacokinetics of furosemide in neonates.

Authors:  P Vert; M Broquaire; M Legagneur; P L Morselli
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Determinants of the diuretic response to furosemide in infants with congestive heart failure.

Authors:  T P Green; B L Mirkin
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

Review 5.  The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications.

Authors:  Melissa A Cadnapaphornchai; Oleksandra Tkachenko; Dmitry Shchekochikhin; Robert W Schrier
Journal:  Pediatr Nephrol       Date:  2013-08-30       Impact factor: 3.714

Review 6.  "Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld.

Authors:  Dietmar Schranz; Norbert F Voelkel
Journal:  Eur J Pediatr       Date:  2016-02-19       Impact factor: 3.183

Review 7.  IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome.

Authors:  Agnes Trautmann; Marina Vivarelli; Susan Samuel; Debbie Gipson; Aditi Sinha; Franz Schaefer; Ng Kar Hui; Olivia Boyer; Moin A Saleem; Luciana Feltran; Janina Müller-Deile; Jan Ulrich Becker; Francisco Cano; Hong Xu; Yam Ngo Lim; William Smoyer; Ifeoma Anochie; Koichi Nakanishi; Elisabeth Hodson; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2020-05-07       Impact factor: 3.714

8.  Contribution of Uptake and Efflux Transporters to Oral Pharmacokinetics of Furosemide.

Authors:  Revathi Chapa; Cindy Yanfei Li; Abdul Basit; Aarzoo Thakur; Mayur K Ladumor; Sheena Sharma; Saranjit Singh; Arzu Selen; Bhagwat Prasad
Journal:  ACS Omega       Date:  2020-12-15

Review 9.  The non-immunosuppressive management of childhood nephrotic syndrome.

Authors:  James McCaffrey; Rachel Lennon; Nicholas J A Webb
Journal:  Pediatr Nephrol       Date:  2015-11-10       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.